The evolution of biosimilars in the United States

Kidney transplantation admissions in the Medicare fee-for-service population

How current Part D risk scores could interact with point-of-sale rebates: Recalibration of RxHCCs for POS rebates could have disparate impacts on plan sponsors 

Product Service Form

General

New York

Siddiqi Hanaa

Please enter a value less than 250 characters.

By clicking this box I acknowledge and consent that any personal data I enter in this form may be stored and processed by Milliman according to the terms of the <a href="https://au.milliman.com/privacy-policy" target="_blank" rel="noopener">Privacy Policy.</a> 

Please enter a message up 800 characters long.

There was a problem submitting your request.

Your message has been sent. We'll be in touch with you shortly.

Please enter a value up to 250 characters long.

Title

The form was not submitted. Please check fields and try again.

Hanaa Siddiqi

Experience

Read their latest work

The evolution of biosimilars in the United States

Kidney transplantation admissions in the Medicare fee-for-service population

How current Part D risk scores could interact with point-of-sale rebates: Recalibration of RxHCCs for POS rebates could have disparate impacts on plan sponsors

CHOOSE A LOCATION AND LANGUAGE